Cancer News and Research

Latest Cancer News and Research

World Cancer Day highlights importance of detection, prevention

"Early diagnosis is the key to reducing the nearly eight million deaths caused by cancer across the globe annually, the United Nations World Health Organization (WHO) said" on Saturday to mark World Cancer Day, "stressing the importance of screening programs for healthy people to detect the disease promptly for easier treatment," the U.N. News Centre reports (2/3).

6 Feb 2012

Body's zinc control mechanisms may be key to aggressive breast cancer treatments

The body's control mechanisms for delivering zinc to cells could be key to improving treatment for some types of aggressive breast cancer.

6 Feb 2012

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.

6 Feb 2012

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.

6 Feb 2012

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples under Endoscopic Ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract.

6 Feb 2012

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.

6 Feb 2012

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.

6 Feb 2012

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

6 Feb 2012

First Edition: February 6, 2012

Today's headlines include reports about the continuing fall out from the Obama administration's birth control rule and the latest on the Komen foundation's efforts to bounce back from the Planned Parenthood funding flap.

6 Feb 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

Russia's first Leksell Gamma Knife Perfexion system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow's Red Square.

From Elekta 6 Feb 2012

EntreMed receives $9.3 million in strategic financing

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.

6 Feb 2012

Humana fourth quarter consolidated revenues increase 9% to $9.06B

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended December 31, 2011 (4Q11) of $1.20, compared to $0.63 per share for the quarter ended December 31, 2010.

6 Feb 2012

McMaster receives $30M gift to accelerate innovations in health research, education and care

A Hamilton family is giving McMaster University $30 million to accelerate the university's innovations in health research, education and care.

6 Feb 2012

U-M develops new system to reduce incidence of retained surgical instruments

It may sound like something from a TV medical drama, but the incidence of surgeons leaving something behind in the body is very real at hospitals across the country. For decades, surgical teams have relied on counting -- and recounting -- the sponges, needles, blades, retractors, and other items used during operations.

6 Feb 2012

Pyromaker can more accurately identify complex genetic mutations

DNA sequencing to detect genetic mutations can aid in the diagnosis and selection of treatment for cancer. Current methods of testing DNA samples, Sanger sequencing and pyrosequencing, occasionally produce complex results that can be difficult or impossible to interpret. Scientists at the Johns Hopkins University School of Medicine have developed a free software program, Pyromaker, that can more accurately identify such complex genetic mutations.

6 Feb 2012

Komen denies cut in Planned Parenthood funding was political

Komen had said the decision was the result of newly adopted criteria barring grants to organizations under investigation - affecting Planned Parenthood because of an inquiry by a Republican congressman. On Thursday, Komen President Elizabeth Thompson told reporters that the funding decision was unrelated to the investigation into whether Planned Parenthood was illegally using federal funds to pay for abortions.

6 Feb 2012

At local level, Komen affiliates express concern about decision

In California, seven Komen groups ask the national breast cancer group to reverse its funding decision. Others report concerns about community support for future money-raising activities.

6 Feb 2012

Tennessee Gov. declares February as 'St. Jude Month'

In 1962, St. Jude Children's Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. At that time, few children with the most common form of childhood cancer survived, and many physicians believed treatment was futile. St. Jude physicians and researchers took a radically different approach, and these efforts proved pivotal in changing the way the world treats childhood cancer.

6 Feb 2012

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.

5 Feb 2012

Komen Foundation seeks to restore public support after ending cuts to Planned Parenthood

The prominent breast cancer charity announced Friday in a blog post that it had reversed this decision, which had stirred an outcry.

5 Feb 2012

Cancer News and Research

Latest Cancer News and Research

World Cancer Day highlights importance of detection, prevention

Body's zinc control mechanisms may be key to aggressive breast cancer treatments

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

First Edition: February 6, 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

EntreMed receives $9.3 million in strategic financing

Humana fourth quarter consolidated revenues increase 9% to $9.06B

McMaster receives $30M gift to accelerate innovations in health research, education and care

U-M develops new system to reduce incidence of retained surgical instruments

Pyromaker can more accurately identify complex genetic mutations

Komen denies cut in Planned Parenthood funding was political

At local level, Komen affiliates express concern about decision

Tennessee Gov. declares February as 'St. Jude Month'

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

Komen Foundation seeks to restore public support after ending cuts to Planned Parenthood

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in